Planning Your Stay for NK Cell Therapy in Japan: A Timeline Guide

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

For international patients considering advanced medical treatments, Japan has become a notable destination, particularly for innovative therapies like NK cell therapy. If you are planning a medical trip to Osaka for this immunotherapy, one of the most practical questions is: “How long do I need to stay?” This article provides a general overview of the time commitment involved in a typical cycle of NK cell therapy to help you plan your journey.

Understanding the Timeline for NK Cell Therapy in Japan

NK (Natural Killer) cell therapy is a type of immunotherapy that utilizes the body’s own immune cells to target abnormal cells, such as cancer cells. The process involves collecting a patient’s own NK cells, activating and expanding them in a specialized facility, and then re-infusing them into the body. Because this process involves a cell culturing period, it is not a single-day procedure. A typical treatment course is structured in cycles, and understanding the duration of one cycle is the first step in planning your stay.

It is important to note that any treatment plan is personalized. The final schedule must be determined through a consultation with a physician, based on your specific health condition and treatment goals. The information here serves as a general guide.

What a Typical Cycle of NK Cell Therapy Involves

A single cycle of NK cell therapy generally consists of three main stages: the initial consultation and blood draw, the cell culturing period, and the infusion. The total duration for one complete cycle typically spans several weeks.

• 1. Initial Consultation and Blood Draw: Your journey begins with a comprehensive consultation with a doctor. During this visit, your medical history will be reviewed, the treatment will be explained in detail, and you will have the opportunity to ask questions. If you decide to proceed, a blood sample (typically around 20-50 mL) will be drawn. This is a standard procedure, similar to a routine blood test. This first visit itself may take a couple of hours.
• 2. Cell Culturing Period: After the blood draw, your sample is sent to a specialized cell processing center. Here, the NK cells are isolated, activated, and multiplied in a controlled environment. This culturing process is crucial for increasing the number and potency of the cells. This phase is the most time-consuming part of the cycle, generally taking about 2 to 3 weeks. During this time, you are not required to be at the clinic.
• 3. NK Cell Infusion: Once the cells have been successfully cultured, you will return to the clinic for the infusion. The expanded NK cells are administered back into your body through an intravenous (IV) drip. The infusion process itself is relatively short, often completed within an hour or so, followed by a brief observation period.

Therefore, a single cycle, from blood draw to infusion, requires a minimum of two visits to the clinic spread out over approximately 2 to 4 weeks.

Planning Your Stay: From a Single Cycle to Multiple Treatments

The overall length of your stay in Japan depends on your treatment plan, which may involve one or multiple cycles. Treatment plans are tailored to each individual’s condition and goals, as determined by the consulting physician.

For a single cycle, you would need to be in Japan for the initial blood draw and the final infusion. This means you might plan for a stay of around 3 to 4 weeks to comfortably accommodate the entire process. Some patients choose to stay in Japan for the duration of the cell culture period, while others may travel back home if logistics permit, returning only for the infusion. This decision depends on travel time, cost, and personal preference.

If your treatment plan involves multiple cycles, the infusions are typically spaced several weeks apart. For example, a plan might consist of 6 infusions administered every 2 to 4 weeks. In such cases, patients may need to plan for a more extended stay in Japan or arrange for multiple trips. It is essential to discuss the feasibility of your travel schedule with the clinic’s medical team and international patient coordinators.

Key Factors Influencing Your Treatment Schedule

Several factors can influence the specific timeline of your NK cell therapy. Being aware of these can help you manage expectations and plan more effectively.

• Individual Health Condition: Your overall health and the specific goals of the therapy will be the primary determinants of your treatment schedule and the number of cycles recommended.
• Cell Processing Schedule: The timeline is dependent on the operational capacity and schedule of the cell processing facility.
• Combination with Other Therapies: If you are combining NK cell therapy with other treatments like chemotherapy or radiation, the schedule will need to be carefully coordinated. NK cell therapy is often used alongside standard treatments, not as a replacement.
• Travel and Logistics: Your personal travel arrangements, visa requirements, and accommodation plans will also play a role in the overall time commitment.

Important Considerations for Medical Travel to Osaka

When considering NK cell therapy in Japan, it’s crucial to understand the context. This treatment is a private medical service not covered by Japanese public health insurance. In Japan, therapies like this are provided under strict regulations. At Grand Green Osaka Umekita Clinic, our NK cell therapy is offered under a treatment plan submitted to and accepted by Japan’s Ministry of Health, Labour and Welfare, in accordance with the Act on the Safety of Regenerative Medicine.

The decision to undergo this therapy should only be made after a thorough consultation with a physician. During this consultation, you will receive detailed information about the expected outcomes, potential risks, and side effects, as well as the full cost. While serious side effects are not commonly reported because the therapy uses your own cells, temporary fever or fatigue can occur after the infusion. For more detailed information about the treatment offered at our clinic, please visit our NK Cell Therapy page.

Next Steps: Preparing for Your Consultation

In summary, a single cycle of NK cell therapy in Japan typically requires a time commitment of several weeks, from the initial blood draw to the final infusion. The total duration of your stay will depend on the number of cycles in your personalized treatment plan. Planning for medical travel requires careful consideration of both the treatment schedule and personal logistics.

The first and most important step is to schedule a consultation. At Grand Green Osaka Umekita Clinic, located in the Umeda area of Osaka, we can help you understand if this therapy is a suitable option for you and provide a clearer picture of the required timeline. A medical consultation is essential to assess your eligibility and create a plan tailored to your needs.

1. 1Consult & Blood DrawYour first visit to the clinic
2. 2Cell Culturing PeriodTakes approx. 2-3 weeks
3. 3NK Cell InfusionReturn to the clinic for treatment
4. 4Repeat CyclesAs per your personalized plan

This is a conceptual diagram to summarize the content of the article

References

• PubMed: Evaluating the safety and feasibility of allogeneic NK cell infusion in high-risk lymphoma patients post-autologous stem cell transplantation. (2025)
• PMC: Abstracts From the 49th Congress of the International Society of Paediatric Oncology (SIOP) Washington, DC, USA October 12-15, 2017. (2017)
• PMC: The 46(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706). (2020)
• PMC: Evaluating the safety and feasibility of allogeneic NK cell infusion in high-risk lymphoma patients post-autologous stem cell transplantation. (2025)
• PMC: Bispecific antibody (ABL602 2 + 1) induced bistable acute myeloid leukemia kinetics. (2024)
• MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.